Verition Fund Management »

Sab Biotherapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $101k 27k 3.74

More positions owned by Verition Fund Management

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Warner Bros Discovery Com Ser A (WBD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Electronic Arts (EA)
Ishares Tr Russell 2000 Etf (IWM)
Palantir Technologies Cl A (PLTR)
Micron Technology (MU)

View all positions for Verition Fund Management

Top funds holding Sab Biotherapeutics

Vivo Capital
RA Capital Management
Commodore Capital
Woodline Partners
Sessa Capital IM
Vanguard Group
BVF
Propel Bio Management
Leucadia National Corporation
HB Wealth Management
Marshall Wace
Simplify Asset Management
AWM Investment Company
Stempoint Capital
Geode Capital Management

View all funds holding Sab Biotherapeutics